Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Smile O2 Eye Drop
- Development stage
- Unknown
- Lead developer
- Optus Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Ophthalmic, Topical
01
Overview
Smile O2 Eye Drop is a preservative-free lubricant eye drop developed by Optus Pharmaceuticals (formerly DHP Korea). It is formulated as a single-dose unit containing sodium chloride, potassium chloride, and glucose. The eye drop is designed to mimic natural tears, providing hydration, electrolyte replenishment, and nutritional support to the ocular surface. It is approved for the relief of eye discomfort and dryness associated with wearing soft or hard contact lenses, dry eye syndrome, eye fatigue, and blurred vision.
- Brand names
- Smile O2Smile O2 Eye Drop
- Other names
- Smile O2 Eye Drop (Single Use)glucose + potassium chloride + sodium chloride스마일오투점안액스마일오투점안액(1회용)
Beyond the preview
Go deeper on Smile O2 Eye Drop.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Smile O2 Eye Drop.